Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV

Journal of Acquired Immune Deficiency Syndromes

Volumn 40, Issue 1, 2005, Pages 96-101

  Castilla, Jesús ^a   Del Romero, Jorge ^b   Hernando, Victoria ^c   Marincovich, Beatriz ^b   García, Soledad ^b   Rodríguez, Carmen ^b  

^a INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^b CENTRO SANITARIO SANDOVAL   (Spain)

^c CARLOS III INSTITUTE OF HEALTH   (Spain)

Author keywords

Antiretroviral therapy; Heterosexual transmission; HIV infection; HIV transmission

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; ARTICLE; DRUG EFFICACY; FEMALE; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRIORITY JOURNAL; SEXUALITY; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COITUS; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HIV-1; HUMANS; INTERVIEWS; MALE; MULTIVARIATE ANALYSIS; PREGNANCY; PREVALENCE; RISK-TAKING; SPAIN; SPOUSES; UNSAFE SEX;

EID: 24144443801     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000157389.78374.45     Document Type: Article

References (26)

1. Royce RA, Seña A, Cates W, et al. Sexual transmission of HIV N Engl J Med. 1997;336:1072-1078.
2. De Vincenzi I, for the European Group on Heterosexual Transmission of HIV. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med. 1994;331:341-346.
3. Saracco A, Musicco M, Nicolosi A, et al. Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. J Acquir Immune Defic Syndr Hum Retrovirol. 1993;6:497-502.
4. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med. 2000;342:921-929.
5. Pedraza MA, del Romero J, Roldan F, et al. Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner. J Acquir Immune Defic Syndr. 1999;21:120-125.
6. Operskalski EA, Stram DO, Busch MP, et al. Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Am J Epidemiol. 1997;146:655-661.
7. Hammer SM, Squires KJE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med. 1997;337:725-733.
8. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.
9. Hosseinipour M, Cohen MS, Vernazza PL, et al. Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? Clin Infect Dis. 2002;34:1291-1295.
10. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001;357:1149-1153.
11. Gray RH, Li X, Wawer MJ, et al. Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS. 2003;17:1941-1951.
12. Xiridou M, Geskus R, de Wit J, et al. The contribution of steady and casual partnership to the incidence of HIV infection among homosexual men in Amsterdam. AIDS. 2003;17:1029-1038.
13. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998. Updated recommendations of the International AIDS Society-USA panel. JAMA. 1998;280:78-86.
14. Gupta P, Mellors J, Kingsley L, et al. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and non-nucleoside reverse transcriptase inhibitors. J Virol. 1997;71:6271-6275.
15. Hart CE, Lennox JL, Pratt-Palmore M, et al. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis. 1999;17:871-882.
16. Musicco M, Lazzarin A, Nocolosi A, et al. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Arch Intern Med. 1994;154:1971-1976.
17. Porco TC, Martin JN, Page-Shafer KA, et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004;18:81-88.
18. Mellors JW, Muñoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126:946-954.
19. Sadiq ST, Taylor S, Kaye S, et al. The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without ureteritis. AIDS. 2002;16:219-225.
20. Ostrow DE, Fox KJ, Chmiel JS, et al. Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS. 2002;16:775-780.
21. Kartz MH, Schwarcz SK, Kellogg TA, et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health. 2002;92:388-394.
22. Miller M, Meyer L, Boufassa F, et al. Sexual behavior changes and protease inhibitor therapy. SEROCO Study Group. AIDS. 2000;14(Suppl): F33-F39.
23. Desquilbet L, Deveau C, Goujard C, et al. Increase in at-risk sexual behavior among HIV-1-infected patients followed in the French PRIMO cohort. AIDS. 2002;16:2329-2333.
24. Van der Straten A, Gomez CA, Saul J, et al. Sexual risk behaviors among heterosexual HIV serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy. AIDS. 2000;14(Suppl):F47-F54.
25. Wolf K, Young J, Rickenbach M, et al. Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2003;33:494-499.
26. Bouhnik AD, Moatti JP, Vlahov D, et al. Highly active antiretroviral treatment does not increase sexual risk behavior among French HIV infected injecting drug users. J Epidemiol Community Health. 2002;56:349-353.